You are currently viewing a new version of our website. To view the old version click .

Most Recent

  • Article
  • Open Access

Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy

  • Xueling Ma,
  • Shuangshuang Liu,
  • Xiao Dong,
  • Xiuhua Li,
  • Feiyan Wang,
  • Jiawei Zhang,
  • Zhenfang Xu,
  • Weiguo Shi,
  • Aiping Zheng and
  • Aiping Zhang
  • + 2 authors
Pharmaceuticals2025, 18(12), 1867;https://doi.org/10.3390/ph18121867 
(registering DOI)

7 December 2025

Background: High expression of nucleolin (NCL) on the surface of tumor cells is closely associated with disease progression and poor prognosis. The aptamer–PROTAC conjugate (APC) technology provides a novel molecular design strategy for the tar...

  • Article
  • Open Access

Integrated Transcriptomic, Proteomic, and Network Pharmacology Analyses Unravel Key Therapeutic Mechanisms of Xuebijing Injection for Severe Acute Pancreatitis

  • Linbo Yao,
  • Xinmin Yang,
  • Mei Yuan,
  • Shiyu Liu,
  • Qiqi Wang,
  • Yongzi Wu,
  • Wenjuan Luo,
  • Xueying Wu,
  • Wenhao Cai and
  • Lan Li
  • + 8 authors
Pharmaceuticals2025, 18(12), 1866;https://doi.org/10.3390/ph18121866 
(registering DOI)

7 December 2025

Background: Xuebijing Injection (XBJ), a plant-derived traditional Chinese medicine administered as an injection, is widely used in clinical practice to treat various acute critical illnesses including severe acute pancreatitis (SAP). The mechanisms...

  • Article
  • Open Access

Structure-Based Virtual Screening for KHK-A Inhibitors with Anti-Hepatocellular Carcinoma Activity

  • Jiang-Yi Zhu,
  • Xiao-Yang Han,
  • Zi-Ying Zhou,
  • Yue-Yue Guo,
  • Hao-Tian Duan,
  • Jia-Jia Shen and
  • Si-Tu Xue
Pharmaceuticals2025, 18(12), 1865;https://doi.org/10.3390/ph18121865 
(registering DOI)

6 December 2025

Background: Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor worldwide and is associated with a poor prognosis. Oxidative stress is a key factor in the occurrence and progression of HCC. KHK-A, a key protein in the oxidative st...

  • Article
  • Open Access

Pine-Extracted Phytosterol β-Sitosterol (APOPROSTAT® Forte) Inhibits Both Human Prostate Smooth Muscle Contraction and Prostate Stromal Cell Growth, Without Cytotoxic Effects: A Mechanistic Link to Clinical Efficacy in LUTS/BPH

  • Alexander Tamalunas,
  • Felix Schierholz,
  • Henrik Poth,
  • Victor Vigodski,
  • Michael Brandstetter,
  • Anna Ciotkowska,
  • Beata Rutz,
  • Sheng Hu,
  • Leo Federico Stadelmeier and
  • Heiko Schulz
  • + 5 authors
Pharmaceuticals2025, 18(12), 1864;https://doi.org/10.3390/ph18121864 
(registering DOI)

6 December 2025

Introduction: Medical treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) targets prostate smooth muscle tone for rapid relieve of symptoms and prostate size to prevent disease progression. Recently, EAU...

  • Article
  • Open Access

An Ongoing Search for Multitarget Ligands as Potential Agents for Diabetes Mellitus and Its Long-Term Complications: New Insights into (5-Arylidene-4-oxothiazolidin-3-yl)alkanoic Acid Derivatives

  • Rosanna Maccari,
  • Rosaria Ottanà,
  • Valerij Talagayev,
  • Roberta Moschini,
  • Francesco Balestri,
  • Francesca Felice,
  • Francesca Iannuccilli,
  • Gemma Sardelli,
  • Rebecca Sodano and
  • Gerhard Wolber
  • + 2 authors

5 December 2025

Background: Diabetes mellitus is a multifactorial disease characterized by complex metabolic dysfunctions and chronic complications induced by hyperglycaemia. The design of multitarget ligands, capable of simultaneously controlling different pathogen...

  • Article
  • Open Access

1-Azinyl-1′-Alkenylferrocenes with Anticholinesterase, Antioxidant, and Antiaggregating Activities as Multifunctional Agents for Potential Treatment of Alzheimer’s Disease

  • Galina F. Makhaeva,
  • Irina A. Utepova,
  • Elena V. Rudakova,
  • Nadezhda V. Kovaleva,
  • Natalia P. Boltneva,
  • Elena Yu. Zyryanova,
  • Alexandra A. Musikhina,
  • Vladimir F. Lazarev,
  • Snezhana A. Vladimirova and
  • Irina V. Guzhova
  • + 6 authors

5 December 2025

Background/Objectives: This study focused on synthesizing novel alkenyl derivatives of azinylferrocenes and evaluating their potential as Alzheimer’s disease (AD) therapeutics. Methods: 1-Azinyl-1′-acetylferrocenes were obtained by regios...

  • Article
  • Open Access

5 December 2025

Background/Objectives: Risk minimization measures, including a pregnancy prevention program (PPP), have been established by the European Medicine Agency to strengthen the restrictions on valproate (VPA) use in pregnant women/women with childbearing p...

  • Article
  • Open Access

Rosuvastatin Versus Atorvastatin for Cardiovascular Disease Risk in Patients with Type 2 Diabetes: A Korean Cohort Study

  • Chaeyoon Kim,
  • Junhyuk Chang,
  • Sujin Gan,
  • Sohyeon Park,
  • Kalynn Park,
  • Hong-Ah Kim,
  • Rae Woong Park and
  • Sandy Jeong Rhie

5 December 2025

Background: Rosuvastatin and atorvastatin are indicated for cardiovascular protection in patients with type 2 diabetes (T2D) but may differ in clinical effectiveness and safety. This study compared real-world cardiovascular and safety outcomes associ...

  • Review
  • Open Access

5 December 2025

Depression, as a highly prevalent psychiatric disorder, has emerged as a global public health challenge. Its pathological mechanisms involve the cross-regulation of multiple pathways, including neurotransmitter imbalance, neuroinflammation, and oxida...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247